Ochsner Connected Health, part of New Orleans-based Ochsner Health, has partnered with Crux to expand access to affordable obesity care through a new employer benefits platform.
Under the agreement, Ochsner will serve as the first cardiometabolic care provider on Crux’s platform, combining remote clinical services with cost-effective access to GLP-1 medications, according to a Jan. 7 Ochsner Health news release. Ochsner will deliver care through its Digital Medicine program, which offers evidence-based treatment for obesity, hypertension and Type 2 diabetes.
Crux, which contracts directly with drug manufacturers, will provide GLP-1 medications using a pass-through pricing model that avoids pharmacy benefit manager involvement and complex reimbursement processes. The combined approach aims to reduce costs while supporting long-term weight management and cardiometabolic health.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
